- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (120)
- Timeline of Article Publication (2)
- Authors Evaluation (3)
- Article Quality Tracking (1)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6409)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 14, 2023 (publication date) through Jun 27, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pan WX, Zhang XM, Hao SL, Han W. Progress in immunotherapy for neuroendocrine neoplasm of the digestive system. World J Gastroenterol 2023; 29(26): 4174-4185 [PMID: 37475845 DOI: 10.3748/wjg.v29.i26.4174] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i26/4174.htm |
| Number | Citing Articles |
| 1 |
Christian Fottner, Leonidas Apostolidis, Sebastian Krug, Anja Rinke, Barbara Grün, Patrick Michl, Thomas M. Gress, Daniel-Christoph Wagner, Wilfried Roth, Esther Mettler, Jana Topsch, Christian Ruckes, Peter R. Galle, Matthias M. Weber. Activity and Safety of Avelumab in High-Grade Neuroendocrine Tumors and Poorly Differentiated Neuroendocrine Carcinomas Progressive after Chemotherapy (AveNEC Trial). Clinical Cancer Research 2025; 31(5): 860 doi: 10.1158/1078-0432.CCR-24-2461
|
| 2 |
John Patresan, Harsh Patel , Angelica Singh. A Neuroendocrine Tumor of Unknown Primary Origin: A Case Report and Review of the Literature. Cureus 2024; doi: 10.7759/cureus.65200
|
| 3 |
Christine Son, Joshua Kalapala, Jeff Leya, Michelle Marion Popadiuk, Mohammed K. Atieh, Daniel Havlichek, Lawrence Feldman, Paul Roach, Promila Banerjee. Gastroesophageal Neuroendocrine Tumors: Outcomes and Management. Journal of Clinical Medicine 2025; 14(7): 2148 doi: 10.3390/jcm14072148
|
| 4 |
Nastasiia Artamonova, Isabel Heidegger. Urologic Cancers - Advances and Challenges in Diagnosis and Molecular Targeted Therapy [Working Title]. 2025; doi: 10.5772/intechopen.1009816
|
| 5 |
Xuan-Peng Zhou, Luan-Biao Sun, Wen-Hao Liu, Xin-Yuan Song, Yang Gao, Jian-Peng Xing, Shuo-Hui Gao. Development and validation of predictive models for distant metastasis and prognosis of gastroenteropancreatic neuroendocrine neoplasms. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-92974-x
|
| 6 |
Jaewoo Park, Min Sung Joo, Myung Jun Kim, Seungseok Oh, Phuong Thao Tran, Minju Kwon, Yong June Choi, JaeYung Lee, Eun-Jung Kim, Dong Hyuk Ki, Hunmi Choi, Wooseok Han, Keon Wook Kang. High cereblon expression in neuroendocrine cancer confers vulnerability to GSPT1 molecular glue degrader. Experimental Hematology & Oncology 2025; 14(1) doi: 10.1186/s40164-025-00674-z
|
| 7 |
舒瑶 张. A Case Report of Nonfunctional Pelvic Neuroendocrine Tumor. Advances in Clinical Medicine 2023; 13(11): 18448 doi: 10.12677/ACM.2023.13112591
|